Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2014

View Archived Issues

Researchers describe mechanism of action of ProHema

Acucela completes enrollment in SEATTLE study of emixustat

Targeting the self-renewal of cancer-initiating cells as a new approach for colorectal cancer

Janssen Pharmaceutica designs new agents for pain

Novel SYK inhibitors synthesized at Novartis

Proteostasis Therapeutics and Cystic Fibrosis Foundation Therapeutics extend collaboration

Cellectar Biosciences begins phase II imaging trial of [124I]CLR-1404

Genticel begins phase II trial in women with high-risk HPV

New milestone reached in Genfit and Sanofi's research collaboration

Viriom begins new program for chronic hepatitis B

International Stem Cell reports interim data from stem cell primate study for Parkinson's disease

Astex receives milestone payment as LEE-011 enters phase III trial

Eisai and Biogen Idec to collaborate in Alzheimer's disease

High 12-week sustained virological response rates in PEARL III study

Vaginal dapivirine effectively protects against HIV challenge

Novartis reports novel SMN modulators for spinal muscular atrophy

New KOR-1 antagonists patented by the Scripps Research Institute

FDA accepts additional Lymphoseek supplemental NDA for review

Kamada initiates phase II/III trials with intravenous Glassia for the treatment of type 1 diabetes

FDA issues complete response letter for empagliflozin

Next-generation sequencing for a rare cancer

Janssen Biotech to begin phase III study of daratumumab in multiple myeloma

FDA grants fast track designation to Tekmira's TKM-Ebola

Regulus Therapeutics initiates phase I study of RG-101

Agenus selects modulator antibodies to advance into preclinical development

iCo Therapeutics updates progress of iDEAL study of iCo-007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...